Cita APA (7a ed.)

Merola, J. F., Behrens, F., Magrey, M., Chen, L., Haaland, D., Kato, K., . . . Lippe, R. (2021). Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study. BMJ Publishing Group.

Cita Chicago Style (17a ed.)

Merola, Joseph F., et al. Upadacitinib in Patients with Psoriatic Arthritis and an Inadequate Response to Non-biological Therapy: 56-week Data from the Phase 3 SELECT-PsA 1 Study. BMJ Publishing Group, 2021.

Cita MLA (8a ed.)

Merola, Joseph F., et al. Upadacitinib in Patients with Psoriatic Arthritis and an Inadequate Response to Non-biological Therapy: 56-week Data from the Phase 3 SELECT-PsA 1 Study. BMJ Publishing Group, 2021.